Heritage Family Offices LLP Buys 159 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Heritage Family Offices LLP raised its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 7.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,274 shares of the company’s stock after acquiring an additional 159 shares during the period. Heritage Family Offices LLP’s holdings in Addus HomeCare were worth $285,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of ADUS. Argent Capital Management LLC raised its holdings in shares of Addus HomeCare by 16.7% during the 4th quarter. Argent Capital Management LLC now owns 45,812 shares of the company’s stock worth $5,743,000 after acquiring an additional 6,555 shares in the last quarter. Redhawk Wealth Advisors Inc. raised its position in Addus HomeCare by 12.0% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 7,762 shares of the company’s stock valued at $973,000 after purchasing an additional 834 shares during the period. Harbor Capital Advisors Inc. increased its position in shares of Addus HomeCare by 1.2% during the 4th quarter. Harbor Capital Advisors Inc. now owns 65,113 shares of the company’s stock valued at $8,162,000 after purchasing an additional 802 shares during the last quarter. Diversified Trust Co boosted its stake in Addus HomeCare by 13.8% during the fourth quarter. Diversified Trust Co now owns 3,072 shares of the company’s stock worth $385,000 after buying an additional 372 shares during the period. Finally, Oliver Luxxe Assets LLC lifted its holdings in shares of Addus HomeCare by 3.3% in the 4th quarter. Oliver Luxxe Assets LLC now owns 17,056 shares of the company’s stock worth $2,138,000 after acquiring an additional 544 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ADUS. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Oppenheimer increased their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Stephens lifted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $133.67.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $131.27 on Thursday. The stock has a market cap of $2.38 billion, a PE ratio of 30.04, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00. The stock has a 50-day moving average of $125.07 and a two-hundred day moving average of $126.29. Addus HomeCare Co. has a one year low of $85.94 and a one year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same period last year, the business earned $1.03 EPS. Addus HomeCare’s revenue for the quarter was up 7.1% on a year-over-year basis. As a group, sell-side analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,750 shares of company stock worth $4,930,750. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.